Search - tctmd.com

Displaying 361 - 375 of 375

Sort: Relevancy | Date

News Conference News

Different Agents Show Potential as Adjuncts to PCI

May 19, 2011

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

April 21, 2011

News Daily News

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

April 11, 2011

News Daily News

GPIs in Elective PCI: Older Drugs Still Have a Role

February 27, 2011

News Daily News

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

February 09, 2011

News Daily News

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

February 06, 2011

News Daily News

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

January 25, 2011

News Daily News

Researchers Accurately Predict Who Will Discontinue Clopidogrel

January 09, 2011

News Daily News

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

January 03, 2011

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2010

January 02, 2011

PLX Pharma - Aspirin for the Interventionalist: More Than Meets the Eye

CME

Aspirin for the Interventionalist: More Than Meets the Eye

Changing Course with Anticoagulation in Secondary Prevention of CAD

CME

Changing Course with Anticoagulation in Secondary Prevention of CAD

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.